MX352176B - Proceso para producir un material inorganico particulado. - Google Patents

Proceso para producir un material inorganico particulado.

Info

Publication number
MX352176B
MX352176B MX2013013135A MX2013013135A MX352176B MX 352176 B MX352176 B MX 352176B MX 2013013135 A MX2013013135 A MX 2013013135A MX 2013013135 A MX2013013135 A MX 2013013135A MX 352176 B MX352176 B MX 352176B
Authority
MX
Mexico
Prior art keywords
inorganic particulate
particulate material
producing inorganic
producing
administration
Prior art date
Application number
MX2013013135A
Other languages
English (en)
Other versions
MX2013013135A (es
Inventor
Maio Mario
Breininger Eugenia
Cabrera Perez Karin
Lang Ulrich
Peters Benjamin
Puchert Thomas
Saal Christoph
Schulz Michael
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2013013135A publication Critical patent/MX2013013135A/es
Publication of MX352176B publication Critical patent/MX352176B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/14—Colloidal silica, e.g. dispersions, gels, sols
    • C01B33/141—Preparation of hydrosols or aqueous dispersions
    • C01B33/142—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates
    • C01B33/143—Preparation of hydrosols or aqueous dispersions by acidic treatment of silicates of aqueous solutions of silicates
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
    • C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
    • C01B33/187—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates
    • C01B33/193—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof by acidic treatment of silicates of aqueous solutions of silicates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Silicon Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)

Abstract

La presente invención se refiere a un proceso para producir un material inorgánico particulado, el material inorgánico particulado que puede obtenerse con el proceso, un sistema de administración con liberación modificada que comprende el material y el uso de el material en la administración de un agente bioactivo.
MX2013013135A 2011-05-13 2012-04-25 Proceso para producir un material inorganico particulado. MX352176B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11003961 2011-05-13
PCT/EP2012/001769 WO2012156023A1 (en) 2011-05-13 2012-04-25 Process for producing inorganic particulate material

Publications (2)

Publication Number Publication Date
MX2013013135A MX2013013135A (es) 2014-02-11
MX352176B true MX352176B (es) 2017-11-13

Family

ID=46022158

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013135A MX352176B (es) 2011-05-13 2012-04-25 Proceso para producir un material inorganico particulado.

Country Status (18)

Country Link
US (1) US9517268B2 (es)
EP (1) EP2707329B1 (es)
JP (1) JP6040497B2 (es)
KR (1) KR101906792B1 (es)
CN (1) CN103534208B (es)
AR (1) AR086346A1 (es)
AU (1) AU2012258092B2 (es)
BR (1) BR112013029149A2 (es)
CA (1) CA2836782A1 (es)
DK (1) DK2707329T3 (es)
EA (1) EA201301264A1 (es)
ES (1) ES2657822T3 (es)
IL (1) IL229209A (es)
MX (1) MX352176B (es)
PT (1) PT2707329T (es)
SG (1) SG194820A1 (es)
WO (1) WO2012156023A1 (es)
ZA (1) ZA201309469B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10577250B2 (en) 2011-05-13 2020-03-03 Merck Patent Gmbh Process for producing of inorganic particulate material
AU2013343906B2 (en) * 2012-11-12 2018-03-01 Merck Patent Gmbh Use of silicon oxide-based material for the modified release of biologically active agents
WO2015078552A1 (en) 2013-11-26 2015-06-04 Merck Patent Gmbh Process for producing inorganic particulate material
JP7200097B2 (ja) 2017-05-19 2023-01-06 株式会社トクヤマ 医薬原体担持体及びその製造方法
CN110133765A (zh) * 2018-02-08 2019-08-16 法国圣戈班玻璃厂 带有耐污层的光学组件及其制备方法和应用
JP7352936B2 (ja) * 2018-08-17 2023-09-29 地方独立行政法人東京都立産業技術研究センター 多孔質シリカ、機能材料および多孔質シリカの製造方法
WO2020127281A1 (en) 2018-12-20 2020-06-25 Merck Patent Gmbh A release system comprising a bioactive agent and a particulate material
WO2021220507A1 (ja) * 2020-05-01 2021-11-04 昭和電工マテリアルズ株式会社 多孔質体形成用塗液、多孔質体及び多孔質体の製造方法
JP6924338B1 (ja) * 2021-01-29 2021-08-25 三井金属鉱業株式会社 ゾル、ゲル及びシリカ多孔体を製造する装置及び方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070216A (en) 1964-03-09 1967-06-01 Grace W R & Co Improvements in or relating to silica and silica-alumina gels
JP3985171B2 (ja) * 1996-12-26 2007-10-03 直弘 曽我 無機系多孔質体の製造方法
ATE225320T1 (de) * 1996-12-26 2002-10-15 Merck Patent Gmbh Anorganisches, poröses material und verfahren zu dessen herstellung
JP3985170B2 (ja) * 1996-12-26 2007-10-03 直弘 曽我 無機系多孔質体の製造方法
KR100517445B1 (ko) 1997-02-24 2005-09-29 다우 코닝 코포레이션 중성-에이징되고 표면적이 감소된 소수성 실리카 겔
WO1999038006A1 (en) 1998-01-23 1999-07-29 Merck Patent Gmbh Process for producing inorganic porous material in a capillary
JPH11292528A (ja) 1998-01-23 1999-10-26 Naohiro Soga 無機多孔質材料の製造法
WO2001012221A1 (en) 1999-08-16 2001-02-22 Henceforth Hibernia, Inc. Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them
CA2729228C (fr) 2001-08-13 2014-11-18 Rhodia Chimie Silices a distribution granulometrique et/ou repartition poreuse particulieres et leurs utilisations, notamment pour le renforcement de polymeres
US8992974B2 (en) 2003-02-24 2015-03-31 Pharmaceuticals Productions, Inc. Transmucosal drug delivery system
GB0315012D0 (en) 2003-06-27 2003-07-30 Leuven K U Res & Dev Zeotiles
JP4519433B2 (ja) * 2003-09-17 2010-08-04 株式会社トクヤマ 微粒子状メソポーラスシリカ
WO2005026048A1 (ja) 2003-09-11 2005-03-24 Taiyo Kagaku Co., Ltd. 物質担持多孔質シリカ
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
US20070224133A1 (en) 2006-03-23 2007-09-27 Mcgill Patrick D High-cleaning silica materials made via product morphology control under high shear conditions
JP2009013142A (ja) 2007-07-09 2009-01-22 Kyoto Univ 徐放用メソポーラスシリカ
CN101348713A (zh) 2007-07-20 2009-01-21 同济大学 能发射荧光的磁性复合纳米微球及其制备方法
CN101113247A (zh) * 2007-09-05 2008-01-30 广州市飞雪化工有限公司 一种透明磨擦粒子的制备方法
CN101250313B (zh) 2008-03-19 2010-12-08 中国科学院化学研究所 纳米粒子复合物及其制备方法
CN101343065A (zh) * 2008-09-04 2009-01-14 复旦大学 一种纳米二氧化硅空心球材料及其制备方法
CN101412517A (zh) * 2008-11-14 2009-04-22 华东理工大学 孔径可控的介孔二氧化硅微球的制备方法及应用
JP5426869B2 (ja) * 2008-11-19 2014-02-26 パナソニック株式会社 メソポーラスシリカ微粒子の製造方法、メソポーラスシリカ微粒子含有組成物、及びメソポーラスシリカ微粒子含有成型物
JP4521477B1 (ja) * 2009-01-15 2010-08-11 水澤化学工業株式会社 非晶質シリカ
CN101559952A (zh) * 2009-05-13 2009-10-21 南京工业大学 一种纳米尺度介孔二氧化硅球的制备方法
CN101829331A (zh) * 2010-05-28 2010-09-15 沈阳药科大学 一种适用于难溶性药物的三维有序大孔二氧化硅给药体系

Also Published As

Publication number Publication date
US20140336274A1 (en) 2014-11-13
CN103534208A (zh) 2014-01-22
ES2657822T3 (es) 2018-03-07
IL229209A (en) 2016-12-29
EP2707329B1 (en) 2017-11-01
CA2836782A1 (en) 2012-11-22
WO2012156023A8 (en) 2014-01-30
AU2012258092A1 (en) 2014-01-09
SG194820A1 (en) 2013-12-30
EA201301264A1 (ru) 2014-04-30
CN103534208B (zh) 2017-07-18
ZA201309469B (en) 2014-08-27
WO2012156023A1 (en) 2012-11-22
PT2707329T (pt) 2018-02-07
BR112013029149A2 (pt) 2017-02-07
MX2013013135A (es) 2014-02-11
JP2014522363A (ja) 2014-09-04
KR101906792B1 (ko) 2018-10-11
DK2707329T3 (en) 2018-01-15
JP6040497B2 (ja) 2016-12-07
US9517268B2 (en) 2016-12-13
EP2707329A1 (en) 2014-03-19
AR086346A1 (es) 2013-12-04
AU2012258092B2 (en) 2015-08-20
KR20140033122A (ko) 2014-03-17
IL229209A0 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
MX352176B (es) Proceso para producir un material inorganico particulado.
PH12014502010A1 (en) Bispecific antibodies against human tweak and human il17 and uses thereof
MD4589B1 (ro) Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
MX2013008390A (es) Preparacion de estructuras de metal-triazolato.
IL229260A0 (en) Preparations, methods and systems for respiratory administration of two or more active agents
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
IN2015KN00262A (es)
PH12013501994A1 (en) Controlled release pharmaceutical dosage forms
MX2013008851A (es) Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias.
FI20116138A7 (fi) Matriisi bioaktiivisten aineiden hallittuun vapauttamiseen
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
MY168300A (en) Pharmaceutical Composition for Inhalation
ZA201509016B (en) Compositions, methods & systems for respiratory delivery of three or more active agents
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
IL243995B (en) Sustained release preparations made of hyaluronic acid, and their medical uses
MX2016006738A (es) Procedimiento para producir material particulado inorganico.
EA026830B9 (ru) Осмотически активная система вагинальной доставки
MX361407B (es) Formulaciones de liberacion controlada de hidrocortisona.
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.
IN2013MU01111A (es)
MX2012014970A (es) Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.
IN2014DN03010A (es)
PH12014500577A1 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles
IN2013CH04314A (es)

Legal Events

Date Code Title Description
FG Grant or registration